MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/17.01.25 Share Price

Warrant

DE000MB1X1V3

Market Closed - Börse Stuttgart 12:22:16 26/06/2024 am IST
0.101 EUR +3.06% Intraday chart for MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/17.01.25
Current month-26.28%
1 month-3.81%
Date Price Change
25/24/25 0.101 +3.06%
24/24/24 0.098 -10.91%
21/24/21 0.11 +4.76%
20/24/20 0.105 +5.00%
19/24/19 0.1 -3.85%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 12:22 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB1X1V
ISINDE000MB1X1V3
Date issued 30/12/2022
Strike 100 $
Maturity 17/01/2025 (206 Days)
Parity 10 : 1
Emission price 1
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.08
Lowest since issue 0.075
Spread 0.004
Spread %3.81%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
132.9 USD
Average target price
142.7 USD
Spread / Average Target
+7.34%
Consensus